Valneva SE (VALN) Gross Profit (QoQ) (2021 - 2026)
Valneva SE (VALN) Gross Profit (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Valneva SE | 839.21 Mn | 719.43 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.48% |
| Dec 31, 2025 | 217.46% |
| Sep 30, 2025 | -108.54% |
| Jun 30, 2025 | -7.55% |
| Mar 31, 2025 | 11.12% |
| Dec 31, 2024 | 47.22% |
| Sep 30, 2024 | 9.71% |
| Jun 30, 2024 | 37.75% |
| Mar 31, 2024 | -33.10% |
| Dec 31, 2023 | -7.40% |
| Sep 30, 2023 | 148.64% |
| Jun 30, 2023 | -47.21% |
| Mar 31, 2023 | 226.31% |
| Dec 31, 2022 | -108.22% |
| Sep 30, 2022 | 245.44% |
| Jun 30, 2022 | -1,179.78% |
| Mar 31, 2022 | -96.80% |
| Dec 31, 2021 | 343.90% |
| Sep 30, 2021 | -2,563.65% |
| Jun 30, 2021 | -51.44% |